“Cancer patients should be given the opportunity to make their own choices regarding hyperthermia cancer treatment devices.”

AdipoLABs holds IVRA, requesting support to improve utilization of terminally ill patients and prove scientific cases

[Medical Newspaper/Daily Newspaper = Reporter Oh In-gyu] “It is not important whether the hyperthermia cancer treatment device is used alone or in combination. “No matter which form it is, giving cancer patients the opportunity to make their own choices comes first.”

AdipoLABs’ CEO Han Sung-ho said this at a press conference held on the 5th floor of the Maria Hall of Seoul St. Mary's Hospital where the IVRA event was held on the 9^th. Various cancer medical experts from many different countries gave lectures on various improvement cases under the theme 'This is how I beat cancer.' stated together.

This approach is emerging as a new hope for cancer patients all around the world as it has a mechanism to generate deep heat through high-frequency wave to the human body and necrotize heat-sensitive cancer cells.

Dr. Eui-shin Kim (a lifetime professor at MD Anderson in Texas, a professor at Seoul National University), an authority on cancer treatment who visited the site on this day, premised that “cancer cannot be treated with a single treatment method, and multiple methods must be used in combination,” but added, “Hyperthermia therapy is definitely helpful to cancer patients since it has almost no side effects and brings upon revitalization of immune system in human body.”

In addition, IVRA CEO Seung-mo Yoo (Director of Yesan Myongji Hospital) and Professor Hong-seok Jang (Department of Radiation Oncology, Seoul St. Mary's Hospital), who were present, pointed out the burden of fees and the limitations of prioritizing existing treatments, and that the limited use situation can change through system improvement and once scientific verification is provided. They also raised their voices requesting support to discover many clinical cases for this purpose.

Sung-ho Han, CEO of AdipoLABs, also said, “We cannot guarantee that 5 years of treatment with REMISSION 1℃ will cure the cancer 100%. However, there are already a number of papers showing that cancer is improved by heat,” he said. “My only hope is that our method will be left as a final opportunity for terminally ill cancer patients who cannot take any measures at home. I want to help them. I know we can be competitive overseas and achieve tremendous results soon.” “He emphasized.

IVRA presents cases of radiofrequency hyperthermia treatment effects and clinical experience

An overview of the IVRA academic seminar held under the theme ‘This is how I overcame cancer’ The IVRA (International Virus Research Alliance) event, now in its 6th year, was successfully conducted as an academic seminar with over 200 foreign cancer treatment specialists, over 300 domestic medical personnel, and cancer patients and their families all invited.

This is an international cancer treatment hope conference where domestic and foreign experts present and discuss various cancer treatment cases focusing on hyperthermia. The academic seminar will cover the role of hyperthermia among various treatment methods for modern malignant tumors, the effectiveness of high-frequency hyperthermia in cancer treatment. Clinical experience, use of heat in cancer treatment, and activation of immunity through hyperthermia therapy were presented and acquired a great deal of attention from attendees.

In fact, high-frequency hyperthermia is a cancer treatment method that uses the heat-sensitive nature of cancer cells to generate the body's own heat and stably induces deep heat to increase body temperature. When administered before treatment, it helps activate the patient's metabolism and immunity. It is known that when combined with chemotherapy, hyperthermia can help improve the treatment effect by far.

Sung-ho Han, CEO of AdipoLABs, the organizer of the event, said, “We will continue to strive to find opportunities for the human body to overcome cancer on its own,” and added, “We will continue to discover clinical cases in Malaysia, where the next event is scheduled to be held, as well as in China and India, and continue to raise the value of our company.” 

Source: “Cancer patients should be given the opportunity to make their own choice when it comes to hyperthermia cancer treatment devices” < Medical devices/IT < Text of article - Medical Newspaper (bosa.co.kr)